- ►diabetesjournals.org S Redondo, E Ruiz, CG Santos-Gallego, E … - Diabetes, 2005 - Am Diabetes Assoc Thiazolidinediones, such as pioglitazone, seem to exert direct
antiatherosclerotic and antirestenotic effects on type 2 diabetes, in part due
to an induction of vascular smooth muscle cell (VSMC) apoptosis. We aimed ... Cited by 33 - Related articles - All 6 versions
- ►ahajournals.org Y Lin, X Zhu, FL Mclntee, H Xiao, J Zhang, M … - Arteriosclerosis, thrombosis, and vascular biology, 2004 - Am Heart Assoc Methods and Results— Using Northern and Western blot analyses, we documented
that PPAR ligands, including ciglitazone, troglitazone, and GW7845,
significantly increased IRF-1 expression in VSMCs; however, the PPAR ligand ... Cited by 25 - Related articles - BL Direct - All 9 versions
- ►aspetjournals.org E Ruiz, S Redondo, A Gordillo-Moscoso, T … - Journal of Pharmacology and Experimental …, 2007 - ASPET Alterations in vascular wall remodeling are a typical complication in type 2
diabetes mellitus due to an imbalance between cell proliferation and apoptosis.
In this context, we have previously shown that vascular smooth muscle cells ... Cited by 9 - Related articles - All 3 versions
- ►ahajournals.org S Lim, CJ Jin, M Kim, SS Chung, HS Park, IK … - Arteriosclerosis, thrombosis, and vascular biology, 2006 - Am Heart Assoc Methods and Results— To investigate the effect of PPAR gene modulation on
neointima formation after balloon injury, we delivered adenoviral vectors
expressing the wild-type (WT) dominant negative (DN) PPAR , or a control ... Cited by 23 - Related articles - All 8 versions
- ►ahajournals.org D Ogawa, T Nomiyama, T Nakamachi, EB … - Circulation Research, 2006 - Am Heart Assoc Activation of the peroxisome proliferator-activated receptor (PPAR) , the
molecular target for insulin sensitizing thiazolidinediones used in patients
with type 2 diabetes, inhibits vascular smooth muscle cell (VSMC) ... Cited by 37 - Related articles - All 7 versions
C Weigert, K Brodbeck, A Bierhaus, HU … - Biochemical and biophysical research communications, 2003 - Elsevier The peroxisome proliferator-activated receptor γ activating compounds
thiazolidinedione (TZD) have been shown to inhibit diabetes-induced glomerular
transforming growth factor-β1 (TGF-β1) expression, thereby ameliorating ... Cited by 25 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org KM Hannan, RJ Dilley, ST de Dios, PJ Little - Arteriosclerosis, thrombosis, and vascular biology, 2003 - Am Heart Assoc Methods and Results— Repair of rat aorta after balloon catheter injury in
troglitazone-treated (400 mg/kg per day by mouth) rats showed early acceleration
of reendothelialization and late reduction in neointima formation. ... Cited by 25 - Related articles - BL Direct - All 6 versions
- ►jbc.org KY Kim, HG Cheon - Journal of Biological Chemistry, 2006 - ASBMB Recent evidence shows that peroxisome proliferator-activated receptor (PPAR )
ligands induce the antiangiogenic effect in endothelial cells and tumors. In the
present study, we elucidated the involvement of maxi-K channel activation ... Cited by 16 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org D Bruemmer, F Yin, J Liu, JP Berger, T Sakai … - Circulation Research, 2003 - Am Heart Assoc From the Division of Endocrinology, Diabetes and Hypertension and The Gonda
(Goldschmied) Diabetes Center (DB, FY, JL, FB, AJVH, REL), David Geffen School
of Medicine, University of California, Los Angeles, Calif; Department of ... Cited by 74 - Related articles - All 4 versions
